Dihuang Yinzi improves scopolamine-induced learning and memory impairment by regulating plasma exosome-derived BDNF
Journal of Ethnopharmacology · 2025
DOI: 10.1016/j.jep.2025.119322 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ethnopharmacology, 2025. Verfasst von Wenna Su und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Shanxi University of Chinese Medicine, Jinzhong, Shanxi, 030619, China; Shanxi Provincial Key Laboratory of Chinese…. Hauptthemen laut MEDLINE: Exosomes, Brain-Derived Neurotrophic Factor, Drugs, Chinese Herbal, Memory Disorders. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Shanxi Provincial Education Department, National Natural Science Foundation of China.
Abstract (Originalsprache)
ETHNOPHARMACOLOGICAL RELEVANCE: Dihuang Drink (DHD), formulated by Liu Hejian during the Yuan Dynasty, is listed as one of the first ancient classical prescriptions by the National Medical Products Administration of China. It is commonly used for the prevention and treatment of Alzheimer's disease (AD). This study further investigates the therapeutic effects and potential mechanisms of DHD in AD. AIM OF THE STUDY: This study aimed to evaluate the cognitive improvement effects of DHD on scopolamine (SCOP)-induced memory impairment in mice and to explore its anti-AD mechanisms mediated by exosomes. MATERIALS AND METHODS: A cognitive impairment model was established in C57BL/6J mice via intraperitoneal injection of SCOP (1 mg/kg) for 21 consecutive days, followed by DHD intervention to assess its effects on learning, memory, hippocampal synaptic density, and the cholinergic system. SD rats were gavaged with DHD (22.00 g/kg) for 7 days, and plasma exosomes were extracted. These exosomes were injected into SCOP-treated mice (2 mg/kg, every other day for 14 days, 7 injections) to verify the role of exosomes in improving cognitive function. Behavioral performance and brain ChAT and BDNF levels were measured. RESULTS: DHD improved learning and memory in SCOP model mice, attenuated neuronal loss and decreases in dendritic spines induced by scopolamine, and modulated the expression of BDNF, SYN-1, PSD95, and M1 mAChR. DHD-derived plasma exosomes further enhanced learning and memory function and significantly increased brain ChAT activity and BDNF levels. CONCLUSIONS: DHD may alleviate cognitive impairment in SCOP model mice, potentially through exosome-mediated neuroprotection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Medical Sciences, Shanxi University of Chinese Medicine, Jinzhong, Shanxi, 030619, China; Shanxi Provincial Key Laboratory of Chinese Medicine Encephalopathy, China; National International Joint Research…
- Shanxi Provincial Key Laboratory of Chinese Medicine Encephalopathy, China; National International Joint Research Center for Molecular Chinese Medicine, China; Shanxi Medical Univerity, Jinzhong, Shanxi, 030619, China.
Förderung
- Shanxi Provincial Education Department
- National Natural Science Foundation of China
Zitieren
APA
Su, W., Du, Y., Wang, W., Li, Q., Zhang, J., & He, W. (2025). Dihuang Yinzi improves scopolamine-induced learning and memory impairment by regulating plasma exosome-derived BDNF. Journal of Ethnopharmacology. https://doi.org/10.1016/j.jep.2025.119322
Vancouver
Su W, Du Y, Wang W, Li Q, Zhang J, He W. Dihuang Yinzi improves scopolamine-induced learning and memory impairment by regulating plasma exosome-derived BDNF. Journal of Ethnopharmacology. 2025. doi:10.1016/j.jep.2025.119322
BibTeX
@article{Su2025,
author = {Su, Wenna and Du, Yuzhong and Wang, Wenting and Li, Qinqing and Zhang, Junlong and He, Wenbin},
title = {Dihuang Yinzi improves scopolamine-induced learning and memory impairment by regulating plasma exosome-derived BDNF},
journal = {Journal of Ethnopharmacology},
year = {2025},
doi = {10.1016/j.jep.2025.119322}
}
EUVIMED